Enorama Pharma AB OMXSTO:ERMA:
Q4 2025 NET SALES AMOUNT TO 1,750 KSEK
Q4 2025 OPERATING RESULT AMOUNTS TO -18,472 KSEK
Enorama Pharma Reports Q4 Net Sales Of SEK 1.75 Million
Earlier from Enorama Pharma Ab
- Balance Sheet For Liquidation Purposes Shows Enorama Pharma Equity Is Less Than Half Of Registered Share Capital
- Enorama Pharma Postpones Publication Of 2025 Report Due To Control Balance Sheet
- Enorama Pharma AB (publ) resolves to postpone the planned extraordinary general meeting
- Enorama Pharma Enters Loan Agreement With DS Global